Adicet Bio, Inc. financial data

Symbol
ACET on Nasdaq
Location
131 Dartmouth Street, 3 Rd Floor, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 923 % -16.9%
Debt-to-equity 18.4 % +9.92%
Return On Equity -68.5 % -7.08%
Return On Assets -57.8 % -5.59%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83.3M shares +1.04%
Common Stock, Shares, Outstanding 83.3M shares +1.03%
Entity Public Float 84.4M USD +10%
Common Stock, Value, Issued 8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 91.1M shares +0.5%
Weighted Average Number of Shares Outstanding, Diluted 91.1M shares +0.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 101M USD +0.04%
General and Administrative Expense 25.4M USD -7.13%
Operating Income (Loss) -126M USD +14.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -119M USD +13.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -119M USD +13.6%
Earnings Per Share, Basic -1 USD/shares +48.4%
Earnings Per Share, Diluted -1 USD/shares +48.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.7M USD -84.5%
Other Assets, Current 690K USD +68.7%
Assets, Current 128M USD -44.1%
Property, Plant and Equipment, Net 19.5M USD -18.7%
Operating Lease, Right-of-Use Asset 12.6M USD -20.8%
Goodwill 0 USD -100%
Other Assets, Noncurrent 225K USD -62.1%
Assets 163M USD -39.4%
Accounts Payable, Current 3.29M USD +73.4%
Employee-related Liabilities, Current 4.95M USD +5.19%
Liabilities, Current 17.1M USD -4.61%
Operating Lease, Liability, Noncurrent 12.4M USD -21%
Other Liabilities, Noncurrent 116K USD 0%
Liabilities 29.6M USD -12.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -41K USD
Retained Earnings (Accumulated Deficit) -557M USD -27%
Stockholders' Equity Attributable to Parent 133M USD -43.3%
Liabilities and Equity 163M USD -39.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -25.4M USD -11.2%
Net Cash Provided by (Used in) Financing Activities -104K USD -100%
Net Cash Provided by (Used in) Investing Activities -2.86M USD -1097%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 83.3M shares +1.03%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -28.4M USD -132%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.6M USD -83.2%
Deferred Tax Assets, Valuation Allowance 119M USD +20.4%
Deferred Tax Assets, Gross 122M USD +19%
Operating Lease, Liability 15.4M USD -19.7%
Depreciation 1.66M USD +3.31%
Payments to Acquire Property, Plant, and Equipment 1.49M USD +524%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD -4.51%
Lessee, Operating Lease, Liability, to be Paid 18.2M USD -21.8%
Property, Plant and Equipment, Gross 43.9M USD +4.15%
Operating Lease, Liability, Current 2.95M USD -13.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.85M USD -31.5%
Deferred Tax Assets, Operating Loss Carryforwards 74.8M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 26.4M USD +42.8%
Operating Lease, Payments 900K USD -40%
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 4.66M USD +4.76%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 5.02M USD +16%
Deferred Tax Assets, Net of Valuation Allowance 3M USD -18.3%
Share-based Payment Arrangement, Expense 16.6M USD -24.9%
Operating Leases, Future Minimum Payments, Due in Three Years 4.01M USD -2.12%
Operating Leases, Future Minimum Payments Due 27M USD -2.15%
Interest Expense 2K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%